Navigation Links
World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition


LOS ANGELES, CA (August 10, 2006) - DoveBid, Inc., (http://www.dovebid.com), the global leader in capital asset auction and valuation services, announced today it will be conducting its 50th global Life Sciences / BioPharma Exchange auction online, on August 15, 2006. The event marks a milestone for the DoveBid.com Life Sciences / BioPharma practice, and is expected to bring to-date total assets sold to over US$1 billion in original acquisition costs. Since the Life Sciences Industry Practice inception in 2003, DoveBid has dedicated global resources to bring best-in-class solutions to market supporting life science, pharmaceutical and healthcare industries.

The DoveBid Life Sciences / BioPharma Exchange enables organizations to proactively address asset management challenges in real time. DoveBid clients consign equipment from global locations and draw from DoveBid's portfolio of dedicated Marketing and Valuation solutions in order to bring the right buyers to the right assets at the right time. Global leaders participating in this program include Pfizer (NYSE:PFE), Bristol-Myers Squibb (NYSE:BMY), Procter & Gamble (NYSE:PG), Schering Corporation (NYSE:SGP), and mid-market competitors. "DoveBid's online Life Sciences marketplace and dedicated marketing deliver higher returns on surplus assets.

They understand our business, asset valuations and the global market for Life Sciences and Pharma equipment. We're seeing very positive results in asset disposition, redeployment and overall execution," said William Carr, Director of Global Sourcing for Pfizer Global R&D, Pfizer.

DoveBid offers both Self-service and Full-service, allowing global organ izations the choice of outsourcing the entire process, or building their own asset catalogues online, with enhanced ease of use guided selling capabilities. Through DoveBid's online industry auction exchanges, their assets immediately become visible to millions of buyers worldwide. DoveBid markets, sells, and manages the entire payment process, and provides access to global resources without the listing fees associated with consumer oriented online auction sites. Participants may bid online, review detailed asset descriptions, equipment catalogs, and online bidding instructions at www.dovebid.com.

"With over ten million capital asset transactions, DoveBid is the standard for valuation, management and disposition of global capital assets. The DoveBid portfolio of professional services and powerful web solutions deliver quantifiable value from the shop floor to the top floor," said Brent Cohen, CEO, DoveBid, Inc.


About DoveBid
DoveBid, Inc. is the global leader in capital asset management and valuation services, helping companies identify, redeploy and dispose of surplus assets through privately negotiated sales, live and online auctions, and industry specific web exchanges supporting key verticals and market segments. The Company provides strategic insight and valuation services for financial reporting, tax, secured lending and planning purposes.

Headquartered in Los Angeles, California, USA, DoveBid has over 67 years of industrial capital asset experience with more than 40 locations in 16 countries. More information on DoveBid can be found at www.dovebid.com or by contacting the company directly at (800) 665-1042 or (650) 571-7400.

DoveBid and the DoveBid logo are registered trademarks of DoveBid, Inc.

Contacts Americas: Asia Pacific: Europe/Middle East/Africa: Josh Prince
+1.650.377.2604
jprince@dovebid.com DoveBid, Inc.
10877 Wilshire Boulevard, Suite 600
Los Angeles, CA 90024, United States
Tel +1.310.775.6700
Fax +1.310.775.6800 DoveBid Singapore Pte Ltd
38 Mosque Street, Singapore 059518
Tel +65.63344266
Fax +65.63340469 DoveBid Trading France SARL
60 rue Marcel Dassault
92100 Boulogne Billancourt, France
Tel +33.(0).1.55.20.06.10
Tel +33.(0).1.55.20.06.11


back to top
'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Preserve Samples for RNA Expression Microarrays RNAlater Around the World
2. RNAlater Around the World: The Art of Processing Difficult Samples
3. The Worlds Best DNase Improved TURBO DNA-free
4. RNase Activity in Mouse Tissue: Classification, Hierarchy, and Methods for Control
5. Advantages of Roche Applied Science amplification products
6. Tools for Proteomic Science II
7. Exploiting the Life Science Data Explosion to Speed New Drug Discovery
8. Automation of the Eppendorf Perfectprep BAC 96 DNA Kit on the Caliper Life Sciences Sciclone ALH 3000
9. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
10. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
11. National Instruments DIAdem -- Complete Your Technical Data Management Framework with Powerful Off-line Analysis, Visualization, and Report Generation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... April 30, 2016 , ... The MIT bioLogic design ... the bioLogic team explored how bacterial properties can be applied to fabric and formed ... bacteria, which move in response to humidity change. The team harvested Natto cells and ...
(Date:4/29/2016)... 2016 According to a ... "Separation Systems for Commercial Biotechnology Market - Global ... 2015 - 2023", the separation systems for commercial ... in 2014 and is projected to expand at ... to reach US$ 19,227.8 Mn in 2023. ...
(Date:4/29/2016)... ... April 29, 2016 , ... Intelligent Implant Systems announced ... FDA via 510(k) for sale in the United States. These components expand the ... fusions. With one-level sales beginning in October of 2015, the company has seen ...
(Date:4/28/2016)... NEW YORK , April 28, 2016 /PRNewswire/ ... biotechnology acceleration company reports the Company,s CEO  was ... capital titled Accelerators Enter When VCs Fear To ... Life Science Leader magazine is an ... work for everything from emerging biotechs to Big ...
Breaking Biology Technology:
(Date:3/8/2016)... N.C. , March 8, 2016   ... sensor technology, today announced it has secured $11M ... by GII Tech, a new venture fund being ... with additional participation from existing investors TDF Ventures ... the funds to continue its triple-digit growth and ...
(Date:3/3/2016)... DE SOTO, Kansas , March 3, ... Plus® to offer Oncimmune,s Early CDT®-Lung, a blood ... detection of lung cancer Early CDT®-Lung test ... individuals. --> Early CDT®-Lung test to its ... --> Oncimmune, a leader in early cancer detection, ...
(Date:3/1/2016)... , March 1, 2016 /PRNewswire/ ... announced the addition of the  "Global ...  report to their offering. ... the addition of the  "Global Biometric ...  report to their offering. --> ...
Breaking Biology News(10 mins):